All proceeds were donated to Preshthi Ishwarlal (6), who is fighting lymphoblastic leukaemia. Her only chance of survival is a stem cell donor. Stem cells often serve as the last hope for children ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

AUCATZYL® (obecabtagene autoleucel) approved by US FDA on November 8, ahead of target PDUFA date of November 16; US commercial launch initiatedBLA approval triggers $30m milestone payment to Autolus ...

When two-year-old Bennett Overshaw was diagnosed with acute lymphoblastic leukemia in 2022, his parents asked their son’s ...

Army Spc. Nicholas Filtz has the heart of a warrior as he faces a battle with cancer. Last year, he was diagnosed with a rare cancer called Acute Lymphoblastic Leukemia, which is a common childhood ...

Autolus Therapeutics ( (AUTL) ) has provided an announcement. Autolus Therapeutics has achieved a pivotal milestone with the FDA’s ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

When Lightning coach Jon Cooper thinks about the legacy he wants to leave in Tampa Bay, winning games and hoisting the ...

A slow pitch softball tournament will bring community members together as they run the bases to raise money for a child’s medical expenses.

Sir David Jason, one of Britain's most beloved actors, has revealed he is "desperately" trying to convince TV producers to ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase ...